State UT
Clinical Trials in Utah
Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 178 actively recruiting studies with Utah sites out of 178 registered in total. The busiest research areas in Utah are Malignant Neoplasm, Advanced Solid Tumor, Heart Failure. Leading sponsors running trials in the state include University of Utah, Eli Lilly and Company, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (30), Phase 2 (47), Phase 3 (49), Phase 4 (6).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Utah
Malignant Neoplasm (3)Advanced Solid Tumor (3)Heart Failure (3)Heart Diseases (3)Cardiovascular Diseases (3)Pulmonary Hypertension (3)Non-Small Cell Lung Cancer (3)Alopecia Areata (2)B Acute Lymphoblastic Leukemia (2)Treatment Resistant Depression (2)Pancreatic Ductal Adenocarcinoma (2)Ischemic Stroke (2)
Frequently Asked Questions — Clinical Trials in Utah
How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 178 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 178. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Malignant Neoplasm, Advanced Solid Tumor, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Utah
NCT04782258 Phase 3
Recruiting
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Ar...
Condition
Autosomal Recessive Polycystic Kidney (ARPKD)
Enrollment
20 pts
Location
United States, Belgium, Germany
Sponsor
Otsuka Pharmaceutical Developm
NCT06258109 N/A
Recruiting
Risk of Recurrent CeAD After Pregnancy
Condition
Cervical Artery Dissection
Enrollment
1,000 pts
Location
United States, Argentina, Austria
Sponsor
University Hospital, Basel, Sw
NCT03604133 N/A
Recruiting
Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Regis...
Condition
Arrhythmia
Enrollment
500 pts
Location
United States
Sponsor
QuesGen Systems Inc
NCT06680830 Phase 2
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Posi...
Condition
Parkinson Disease
Enrollment
150 pts
Location
United States, Israel, Italy
Sponsor
Neuron23 Inc.
NCT06423430 N/A
Recruiting
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Condition
Treatment Resistant Depression
Enrollment
100 pts
Location
United States
Sponsor
Abbott Medical Devices
NCT07361328 N/A
Recruiting
Personalized Ultrasonic Brain Stimulation for Fibromyalgia
Condition
Fibromyalgia (FM)
Enrollment
50 pts
Location
United States
Sponsor
University of Utah
NCT06881069 N/A
Recruiting
Reach Through Equitable Implementation in Utah
Condition
Tobacco Use Cessation
Enrollment
1,560 pts
Location
United States
Sponsor
University of Utah
NCT07671677 N/A
Recruiting
BOdygUardian MOnitoriNg for ReCurrencE of AF
Condition
Atrial Fibrillation (AF)
Enrollment
100 pts
Location
United States
Sponsor
Heart Rhythm Clinical and Rese
NCT06941272 Phase 1, Phase 2
Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
50 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT07782619 N/A
Recruiting
Agreement of Two OCT Biometers: A Pilot Study
Condition
Anterior Segment of Eye
Enrollment
50 pts
Location
United States
Sponsor
Alcon Research
NCT07412756 Phase 3
Recruiting
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Condition
Depressive Disorder, Major
Enrollment
1,000 pts
Location
United States, Australia, Brazil
Sponsor
Eli Lilly and Company
NCT07028853 Phase 3
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrom...
Condition
Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT05183854 Phase 2
Recruiting
Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chroni...
Condition
Chronic Lymphocytic Leukemia
Enrollment
61 pts
Location
United States
Sponsor
University of Utah
NCT07326566 Phase 2
Recruiting
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM...
Condition
Glioblastoma (GBM)
Enrollment
162 pts
Location
United States
Sponsor
Black Diamond Therapeutics, In
NCT06310031 N/A
Recruiting
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart ...
Condition
Cardiovascular Diseases
Enrollment
780 pts
Location
United States
Sponsor
BrioHealth Solutions, Inc.
NCT06701669 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Parid...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
NCT05948566 Phase 2
Recruiting
Strategy for Improving Stroke Treatment Response
Condition
Ischemic Stroke
Enrollment
300 pts
Location
United States
Sponsor
Translational Sciences, Inc.
NCT07436156 Phase 4
Recruiting
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Condition
Acute Ischemic Stroke
Enrollment
500 pts
Location
United States
Sponsor
Route 92 Medical, Inc.
NCT07093177 N/A
Recruiting
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
Condition
Prostate Cancer
Enrollment
30 pts
Location
United States
Sponsor
University of Utah
NCT07293351 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or...
Condition
Advanced Renal Cell Carcinoma (RCC)
Enrollment
474 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT00920972 Phase 1, Phase 2
Recruiting
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Condition
Metabolic Disorders
Enrollment
220 pts
Location
United States, Canada
Sponsor
Washington University School o
NCT06578195 N/A
Recruiting
ASSESS ALL ALS Study
Condition
Amyotrophic Lateral Sclerosis
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
St. Joseph's Hospital and Medi
NCT06227377 Phase 1
Recruiting
QTX3034 in Patients With KRAS G12D Mutation
Condition
Solid Tumors
Enrollment
250 pts
Location
United States
Sponsor
Quanta Therapeutics
NCT07231471 N/A
Recruiting
Platelet Rich Plasma for Musculoskeletal Conditions
Condition
Osteoarthritis (OA)
Enrollment
10,000 pts
Location
United States
Sponsor
University of Utah
NCT07278375 N/A
Recruiting
Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal...
Condition
Neonatal Opioid Withdrawal Syndrome
Enrollment
796 pts
Location
United States
Sponsor
HELP for NOWS Consortium
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology